ArticleJournal for immunotherapy of cancer2021

Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation.

Chantal Saberian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.